Cargando…

Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)

Soft tissue sarcomas (STS) constitute an uncommon and heterogeneous group of tumours, which require a complex and specialized multidisciplinary management. The diagnostic approach should include imaging studies and core needle biopsy performed prior to undertaking surgery. Wide excision is the mains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia del Muro, Xavier, de Alava, Enrique, Artigas, Vicenç, Bague, Silvia, Braña, Alejandro, Cubedo, Ricardo, Cruz, Josefina, Mulet-Margalef, Nuria, Narvaez, Jose A., Martinez Tirado, Oscar, Valverde, Claudia, Verges, Ramona, Viñals, Joan, Martin-Broto, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706580/ https://www.ncbi.nlm.nih.gov/pubmed/26563256 http://dx.doi.org/10.1007/s00280-015-2809-5

Ejemplares similares

GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)
por: Poveda, Andrés, et al.
Publicado: (2014)

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
por: Mora, J, et al.
Publicado: (2017)

Malignant bone tumors (other than Ewing’s): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)
por: Redondo, Andrés, et al.
Publicado: (2017)

Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS)
por: Álvarez Álvarez, Rosa, et al.
Publicado: (2023)

Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)
por: Pérez-Fidalgo, Jose Alejandro, et al.
Publicado: (2023)

Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
por: Gronchi, Alessandro, et al.
Publicado: (2019)

A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study
por: Martínez-Trufero, Javier, et al.
Publicado: (2021)

Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)
por: López-Pousa, A., et al.
Publicado: (2006)

CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
por: Moura, David S., et al.
Publicado: (2020)

Bcl-x(L) inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas
por: Rello-Varona, Santi, et al.
Publicado: (2019)

2023 GEIS Guidelines for gastrointestinal stromal tumors
por: Serrano, César, et al.
Publicado: (2023)

Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS)
por: Poveda, A., et al.
Publicado: (2005)

The Importance of Being Dead: Cell Death Mechanisms Assessment in Anti-Sarcoma Therapy
por: Rello-Varona, Santiago, et al.
Publicado: (2015)

REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
por: Martin-Broto, Javier, et al.
Publicado: (2023)

Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study
por: López-Pousa, A, et al.
Publicado: (2006)

Optimization of the Therapeutic Approach to Patients with Sarcoma: Delphi Consensus
por: Álvarez Álvarez, Rosa, et al.
Publicado: (2019)

Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study
por: Maurel, Joan, et al.
Publicado: (2016)

Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study
por: Fernandez-Serra, Antonio, et al.
Publicado: (2020)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)
por: López-Pousa, A., et al.
Publicado: (2016)

Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy
por: Virgili Manrique, Anna C., et al.
Publicado: (2022)

Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives
por: Mulet-Margalef, Nuria, et al.
Publicado: (2016)

SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022)
por: Serrano, César, et al.
Publicado: (2023)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)
por: de Juan Ferré, A., et al.
Publicado: (2021)

Targeted Therapies in Sarcomas: Challenging the Challenge
por: Martín Liberal, Juan, et al.
Publicado: (2012)

Caveolin-1 in sarcomas: friend or foe?
por: Sáinz-Jaspeado, Miguel, et al.
Publicado: (2011)

Cancer Stem Cells in Soft-Tissue Sarcomas
por: Martínez-Delgado, Paula, et al.
Publicado: (2020)

WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
por: Martinez-Font, Esther, et al.
Publicado: (2021)

Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial
por: Martin-Broto, Javier, et al.
Publicado: (2020)

Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center
por: Hindi, Nadia, et al.
Publicado: (2020)

EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1
por: Sáinz-Jaspeado, Miguel, et al.
Publicado: (2013)

Capacity-building efforts by the AFHSC-GEIS program
por: Sanchez, Jose L, et al.
Publicado: (2011)

Antimicrobial resistance surveillance in the AFHSC-GEIS network
por: Meyer, William G, et al.
Publicado: (2011)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Exosomes in Bone Sarcomas: Key Players in Metastasis
por: Chicón-Bosch, Mariona, et al.
Publicado: (2020)

Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma
por: Salguero-Aranda, Carmen, et al.
Publicado: (2022)

A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin
por: Moura, David S., et al.
Publicado: (2021)

Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID‐19 Pandemic
por: Martin‐Broto, Javier, et al.
Publicado: (2020)

Extremities Soft Tissue Sarcomas, more Common and as Dangerous as Bone Sarcomas
por: Voltan, Karen, et al.
Publicado: (2021)

Retroperitoneal soft tissue sarcoma
por: Zepeda, Ernesto, et al.
Publicado: (2007)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5h6muu9g0sveg8om78nbne2lf8